Akebia Therapeutics, Inc. (AKBA) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.02 | +93.9% |
| 2024 | $-0.33 | -17.9% |
| 2023 | $-0.28 | +46.2% |
| 2022 | $-0.52 | +69.4% |
| 2021 | $-1.70 | +38.8% |
| 2020 | $-2.78 | -17.8% |
| 2019 | $-2.36 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.02 | +93.9% |
| 2024 | $-0.33 | -17.9% |
| 2023 | $-0.28 | +46.2% |
| 2022 | $-0.52 | +69.4% |
| 2021 | $-1.70 | +38.8% |
| 2020 | $-2.78 | -17.8% |
| 2019 | $-2.36 | — |